Contact Us

IND Enabling Workshop

London, April 28 2026

Accelerate Your Path From Discovery to First in Human

Join our expert consulting team for a focused, in person workshop designed to help emerging biotechs and startups understand a clear, streamlined, and scientifically robust IND enabling roadmap.

In this interactive workshop, you will experience the complexities and issues of early drug development, developing a hypothetical cardiometabolic drug from discovery to First-In-Human in one afternoon.

What You'll Learn

  • A proven framework to reduce development risk and fast‑track your asset to clinic

Strategic IND‑Enabling Thinking

  • The importance of the Target Product Profiles (TPP) and the impact on drug development.
  • Linking CMC, nonclinical, clinical and regulatory workstreams to create one cohesive plan

CMC, Nonclinical & Clinical Development Insights

  • Manufacturing, stability, and analytical method considerations
  • (GLP) tox, PK/ADME expectations
  • Human dose prediction & early clinical trial design best practices and the importance of KOLs

Translational Laboratory Solutions

  • End to end biomarker strategy from identification to clinical application



Who Should Attend

Built for founders, CSOs, COOs, and R&D leaders at:

  • Startups and scale-ups
  • Early to mid stage biotechs
  • Companies preparing for Preclinical → First in Human

Why Attend

You’ll walk away with:

  • Practical insights in common drug development issues and how to solve them
  • A streamlined pathway toward IND submission
  • Insights from experts who operate as an extension of biotech project teams
  • A clear view on a roadmap that reduces risk, improves decision-making, and accelerates timelines

When and Where

  • April 28, 13:00 - 17:30
  • 40 Bank Street, Floor 24, Canary Wharf

Register Now

Stay connected

Sign up to our emails and follow us on social media to keep up to date with hVIVO.

By clicking Sign Up you're confirming that you agree with our Privacy Policy.
chevron-downarrow-up